Ebunat 0.5mg Injection
By Ebunat
Rx
1 Injection in a Vial

Composition
Eribulin Mesylate(0.5mg)

Manufacturer - Natco Pharma Ltd
Natco House, Road No.2, Banjara Hills, Hyderabad-500 034, India

Expires on or after
July, 2025

liver
When using Ebunat 0.5mg Injection, it is important to be cautious if you have liver disease. Patients with liver issues may require a dose adjustment when taking Ebunat 0.5mg Injection. It is advisable to consult your doctor regarding the use of this medication to ensure it is safe and appropriate for your condition.

kidney
Ebunat 0.5mg Injection requires caution in patients with kidney disease. Dose adjustment may be necessary. Consult your doctor for guidance.

alcohol
Consult your doctor when consuming alcohol with Ebunat 0.5mg Injection.

driving
Ebunat 0.5mg Injection can reduce alertness, impair vision, and cause drowsiness and dizziness. Avoid driving if experiencing these symptoms.

pregnancy
Ebunat 0.5mg Injection should not be used during pregnancy due to potential risks to the developing baby. Consult your doctor for advice, as it may be prescribed in life-threatening situations where benefits outweigh risks.

breastfeeding
It is better to consult your doctor before using Ebunat 0.5mg Injection.
Habit Forming | No |
Chemical Class | Synthetic analogue of halichondrin B |
Therapeutic Class | - |
Action Class | Antimicrotubule agents- Non Taxanes |
₹19600
Inclusive of all taxes
Content verified by

Dr. Upasana Bhatia
MBBS - General Medicine
Last update on 11-Feb-2025